Clinical trial
Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared…
NCT00320229 · Azienda Sanitaria Ospedaliera, Other · Terminated
Key facts
| NCT number | NCT00320229 |
|---|---|
| Title | Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen |
| Lead sponsor | Azienda Sanitaria Ospedaliera, Other |
| Collaborators | Cardiologia 2 - Emodinamica - Ospedale Maggiore, Novara, Italy |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | abciximab |
| Enrollment | 84 |
| Start date | Dec 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | May 3, 2006 |
| Last update posted | May 16, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: